ClinicalTrials.gg
Not yet recruitingNCT07927387Updated Nov 10, 2026

Health Information Framing, Source Characteristics, and Health Behavior Promotion

An interventional study of AI-sourced gain-framed message (Component 1) and AI-sourced loss-framed message (Component 1) in Vaccination, Mental Health and Health Behavior, sponsored by Peking University. Not yet recruiting at 2 sites in China. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Primary conditionHealth BehaviorRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Health Behavior
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Health Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Peking University · Not applicable, Interventional, and Health services research

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
102,000
Allocation
Randomized
Ages
10 Years and older
Sex
All
01

Study summary

This study examines how different ways of presenting health information affect health-related understanding, decision-making, and behavior. It includes two connected research components: one focuses on vaccination-related decisions, and the other focuses on mental health and help-seeking. Participants will complete an online questionnaire and will be randomly assigned to different information conditions that vary in message framing, information source, social norms, and presentation format. The study will compare post-exposure decision intentions and behavioral responses across the assigned conditions. No medicines, vaccines, or medical devices will be administered as part of the study.

Read the detailed description

Health information can influence how people understand health risks, evaluate available options, and make health-related decisions. This prospective behavioral study will use an online questionnaire and a randomized parallel-group design to evaluate how different characteristics of health information affect health-related decision intention and behavioral responses.

The study consists of two connected components conducted in different participant populations and regions. The first component examines how the source and framing of vaccination-related information influence participants' evaluation, decision intention, trust, and subsequent behavioral choices. The second component examines how differently framed mental health information, source cues, and social norms influence mental health-related decision-making and help-seeking responses.

In each component, eligible participants will provide informed consent and will be randomly assigned through an online survey platform to one of several pre-specified information conditions or a comparison condition. Outcomes will be assessed through self-reported questionnaire measures and behavioral responses recorded by the survey platform, including the decision to view further information or proceed with an available follow-up action.

The study does not administer or evaluate the safety or efficacy of any drug, biological product, vaccine, or medical device. All study procedures will be conducted using a secure online platform in accordance with the approved study protocol and applicable ethical requirements.

02

Conditions studied

  • Vaccination
  • Mental Health
  • Health Behavior
  • Health Communication

Browse trials for

Keywords

  • health information
  • health communication
  • message framing
  • information source
  • source credibility
  • social norms
  • HPV vaccination
  • mental health
  • help-seeking
  • health behavior
  • artificial intelligence
  • randomized behavioral study
  • China
03

In context

Health Behavior Reclassified

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's planned enrollment of 102,000 is above the median of 150 across 824 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Peking University is the lead sponsor of 419 studies on the registry; 123 are open to participants now.

Compared within Health Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 10 years or older.
  • Component 1: Young adults entering higher education who meet the age and enrollment requirements specified in the approved protocol.
  • Component 2: Adolescents and their primary caregivers who meet the age, grade, recruitment-site, and paired-participation requirements specified in the approved protocol.
  • Able to understand the study information and complete the online questionnaire with any assistance permitted by the approved protocol.
  • Voluntarily participates and provides electronic . For minors, guardian consent and participant assent are obtained as required.

Exclusion criteria

Exclusion Criteria:

  • Unable to provide or, where applicable, guardian consent and participant assent.
  • Does not meet the eligibility requirements for either study component.
  • Component 1: Has already completed the relevant full vaccination schedule, where specified as an exclusion criterion in the approved protocol.
  • Questionnaire response is invalid because of severe missingness, an implausible completion time, failed quality-control items, or clear logical inconsistency.
  • Any additional component-specific exclusion criterion specified in the approved protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102,000 participants (estimated)

Study arms

  • No intervention
    No-information control (Component 1)
  • Experimental
    AI-sourced gain-framed message (Component 1)

    Behavioral: AI-sourced gain-framed message (Component 1)

  • Experimental
    AI-sourced loss-framed message (Component 1)

    Behavioral: AI-sourced loss-framed message (Component 1)

  • Experimental
    AI-sourced normative message (Component 1)

    Behavioral: AI-sourced normative message (Component 1)

  • Experimental
    AI-sourced structured message (Component 1)

    Behavioral: AI-sourced structured message (Component 1)

  • Experimental
    AI-sourced expert-authority message (Component 1)

    Behavioral: AI-sourced expert-authority message (Component 1)

  • Experimental
    Official gain-framed message (Component 1)

    Behavioral: Official gain-framed message (Component 1)

  • Experimental
    Official loss-framed message (Component 1)

    Behavioral: Official loss-framed message (Component 1)

  • Experimental
    Official normative message (Component 1)

    Behavioral: Official normative message (Component 1)

  • Experimental
    Official structured message (Component 1)

    Behavioral: Official structured message (Component 1)

  • Experimental
    Official expert-authority message (Component 1)

    Behavioral: Official expert-authority message (Component 1)

  • Experimental
    Gain-framed peer message (Component 2)

    Behavioral: Gain-framed peer message (Component 2)

  • Experimental
    Gain-framed expert message (Component 2)

    Behavioral: Gain-framed expert message (Component 2)

  • Experimental
    Loss-framed peer message (Component 2)

    Behavioral: Loss-framed peer message (Component 2)

  • Experimental
    Loss-framed expert message (Component 2)

    Behavioral: Loss-framed expert message (Component 2)

  • Experimental
    Social-norm message (Component 2)

    Behavioral: Social-norm message (Component 2)

  • No intervention
    Blank-reminder control (Component 2)

Interventions

  • BehavioralAI-sourced gain-framed message (Component 1)

    Participants view an AI-sourced message emphasizing the benefits of vaccination.

  • BehavioralAI-sourced loss-framed message (Component 1)

    Participants view an AI-sourced message emphasizing the risks of not being vaccinated.

  • BehavioralAI-sourced normative message (Component 1)

    Participants view an AI-sourced message emphasizing social or public-health approval of vaccination.

  • BehavioralAI-sourced structured message (Component 1)

    Participants view an AI-sourced message explaining vaccination and booking procedures in a structured format.

  • BehavioralAI-sourced expert-authority message (Component 1)

    Participants view an AI-sourced message attributed to professional or expert authority.

  • BehavioralOfficial gain-framed message (Component 1)

    Participants view an official message emphasizing the benefits of vaccination.

  • BehavioralOfficial loss-framed message (Component 1)

    Participants view an official message emphasizing the risks of not being vaccinated.

  • BehavioralOfficial normative message (Component 1)

    Participants view an official message emphasizing social or public-health approval of vaccination.

  • BehavioralOfficial structured message (Component 1)

    Participants view an official message explaining vaccination and booking procedures in a structured format.

  • BehavioralOfficial expert-authority message (Component 1)

    Participants view an official message attributed to professional or expert authority.

  • BehavioralGain-framed peer message (Component 2)

    Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, with peer social cues.

  • BehavioralGain-framed expert message (Component 2)

    Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, attributed to an expert source.

  • BehavioralLoss-framed peer message (Component 2)

    Participants view a loss-framed message emphasizing the risks of not seeking mental health support, with peer social cues.

  • BehavioralLoss-framed expert message (Component 2)

    Participants view a loss-framed message emphasizing the risks of not seeking mental health support, attributed to an expert source.

  • BehavioralSocial-norm message (Component 2)

    Participants view a message presenting help-seeking as a common and socially approved behavior.

06

What researchers measure

Primary outcomes

  1. HPV vaccination intention

    In the Hunan population, assessed immediately after exposure with one 5-point item: "I am willing to receive the HPV vaccine in the future." Responses range from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate stronger intention to receive the HPV vaccine.

    Time frame: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

  2. Professional mental health help-seeking intention

    In Tongzhou students and primary caregivers, assessed using three 7-point items asking how likely the participant would be to seek help from a psychologist, a psychiatrist, and another doctor if experiencing persistent emotional distress or thoughts of self-harm. Scores range from 1 (definitely would not) to 7 (definitely would). The mean of the three items will be calculated; higher scores indicate stronger professional help-seeking intention.

    Time frame: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

  3. HPV vaccination booking-directed action

    In the Hunan population, a binary behavioral outcome recorded by the online questionnaire platform after exposure. A positive response is defined as either selecting direct booking at the first decision point or agreeing to provide contact information for HPV vaccination booking at the end of the booking pathway. Viewing information without proceeding to booking or providing contact information is not counted as a positive response.

    Time frame: During the same online session immediately after exposure to the assigned health information condition.

Secondary outcomes

  1. HPV vaccine trust

    In the Hunan population, assessed with five HPV-adapted Vaccine Trust Gauge items covering vaccine safety, protection against serious illness, relative health risk, benefits versus risks, and effectiveness. Responses will be scored in the direction of greater trust using the prespecified VTG scoring and missing response rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

    Time frame: Immediately after exposure to the assigned health information condition.

  2. Trust in HPV vaccine information sources

    In the Hunan population, assessed with five Vaccine Trust Gauge-adapted items measuring trust in HPV vaccine recommendations from schools or official institutions, doctors or nurses, family or friends, classmates or peers, and social media. Responses will be scored using the same prespecified VTG rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

    Time frame: Immediately after exposure to the assigned health information condition.

  3. HPV vaccination readiness (7C-based)

    In the Hunan population, assessed using seven HPV-adapted 7C vaccination- readiness items covering calculation, collective responsibility, confidence in the system, confidence in vaccine safety, social conformity, convenience or constraints, and complacency. Items will be reverse scored where required and averaged so that higher scores indicate greater vaccination readiness.

    Time frame: Immediately after exposure to the assigned health information condition.

  4. Perceived susceptibility to HPV infection

    In the Hunan population, assessed using the mean of three 5-point Health Belief Model items representing perceived susceptibility to HPV infection. Items will be reverse scored as specified in the analysis plan so that higher scores indicate greater perceived susceptibility.

    Time frame: Immediately after exposure to the assigned health information condition.

  5. Perceived severity of HPV infection

    In the Hunan population, assessed using one reverse-scored 5-point Health Belief Model item concerning whether the health effects of HPV infection are not serious. The score will be transformed so that higher scores indicate greater perceived severity.

    Time frame: Immediately after exposure to the assigned health information condition.

  6. Perceived barriers to HPV vaccination

    In the Hunan population, assessed using the mean of six 5-point Health Belief Model items concerning perceived drawbacks, cost, insufficient information, uncertain long-term side effects, sexual stigma, and sensitivity of the topic. Higher scores indicate greater perceived barriers to HPV vaccination.

    Time frame: Immediately after exposure to the assigned health information condition.

  7. Cues to action for HPV vaccination

    In the Hunan population, assessed using the mean of two 5-point Health Belief Model items concerning exposure to media reports promoting HPV vaccination and the influence of a doctor's recommendation. Higher scores indicate stronger cues to action.

    Time frame: Immediately after exposure to the assigned health information condition.

  8. Help-seeking efficacy attitudes related to mental health

    In Tongzhou students and primary caregivers, assessed using the Help-Seeking dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Five applicable items are used in students and four in caregivers. Items are scored on a 5-point scale, averaged, and rescaled to 0-100. Higher scores indicate more favorable help-seeking attitudes.

    Time frame: Immediately after exposure to the assigned school-based health message.

  9. Stigma-related attitudes toward mental health

    In Tongzhou students and primary caregivers, assessed using the three-item Stigma dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Items are scored on a 5-point scale, averaged, and rescaled to 0-100 in the direction of less stigmatizing and more favorable attitudes.

    Time frame: Immediately after exposure to the assigned school-based health message.

  10. Intention to use generative AI for HPV vaccination information

    In the Hunan population, assessed using two post-exposure 5-point items asking whether the participant is willing to use an AI chatbot to obtain further HPV vaccination information and whether generative AI would be used as one source of HPV vaccination information. Both items will be coded in the direction of greater intention and averaged.

    Time frame: Immediately after exposure to the assigned health information condition.

  11. Benevolence dimension of trust in generative AI for health information

    In Hunan and Tongzhou participants, assessed using the three-item Benevolence dimension of the Human-Generative AI Trust Scale, adapted to HPV vaccination or mental health information. The items assess whether generative AI acts in the participant's best interest, is willing to understand the participant's needs and preferences, and will help to the best of its ability. Items use a 5-point response scale and are averaged; higher scores indicate greater benevolence-based trust.

    Time frame: Immediately after exposure to the assigned health information condition.

  12. Competence dimension of trust in generative AI for health information

    In Hunan and Tongzhou participants, assessed using the three-item Competence dimension of the Human-Generative AI Trust Scale. The items assess whether generative AI can effectively support the participant in understanding health information, performs well in providing health information support, and has the expected functions for that role. Items use a 5-point response scale and are averaged; higher scores indicate greater competence-based trust.

    Time frame: Immediately after exposure to the assigned health information condition.

  13. Reciprocity or dependency dimension of trust in generative AI for health information

    In Hunan and Tongzhou participants, assessed using the three-item Reciprocity or Dependency dimension of the Human-Generative AI Trust Scale. The items assess whether participants believe they can rely on generative AI, whether it can continue to support health decisions, and whether they refer to health information provided by generative AI. Items use a 5-point response scale and are averaged; higher scores indicate greater reciprocity-based trust.

    Time frame: Immediately after exposure to the assigned health information condition.

  14. Psychological resilience

    In Tongzhou students and primary caregivers, assessed immediately after exposure using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Each item is scored from 0 (not true at all) to 4 (true nearly all the time). The 10 item scores are summed to a total score ranging from 0 to 40; higher scores indicate greater psychological resilience. If the online platform stores responses as 1-5, scores will be recoded to 0-4 before summation.

    Time frame: Immediately after exposure to the assigned school-based health message.

07

Study locations

2 sites
  • Beijing Tongzhou Psychiatric Hospital
    Beijing, Beijing Municipality 101118, China
  • The Third Xiangya Hospital of Central South University
    Changsha, Hunan, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07927387
Lead sponsor
Peking University
Responsible party
Jing Guo (Research Associate Professor of Health Policy and Management, School of Public Health, Peking University, Peking University) — Principal investigator
First posted
Nov 10, 2026
Start date
Nov 28, 2026 (estimated)
Primary completion
Nov 28, 2029 (estimated)
Completion
Nov 28, 2029 (estimated)
Last update
Nov 10, 2026

Study contacts

Jing Guo, PhD
Contact
jing624218@163.com
86+18086471505

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion